The company in question is, Mylan N.V. (NASDAQ:MYL) currently with a stock price of 46.6 (-0.57% today). The market cap for Mylan N.V. is 23785.2, and is in the sector Healthcare, and Drugs – Generic industry. The target price for Mylan N.V. is 58.13. Currently Mylan N.V. is trading with a P/E of 29.96, and a forward P/E of 8. Average volume for Mylan N.V. is 4981.71 and so far today it is 908522.
Performance in the last year for Mylan N.V. has been -30.99%. For EPS growth, Mylan N.V. has seen a growth of -31.50%, and is looking to grow in the next year to 18.48%. More long term stats show that EPS growth has been 20.20% over the last five years and could be 13.98% for the next five years. Mylan N.V. has seen sales growth quarter over quarter at 17.10%, with EPS growth quarter over quarter at -78.60%. The 20-day simple moving average is 6.29%, with the 200-day simple moving average coming to -0.36%.
Since the IPO date for Mylan N.V. on the 12/18/1987, Mylan N.V. has seen performance year to date to be -13.33%. With Mylan N.V. trading at 46.6, the dividend yield is *TBA, and the EPS is 1.56.
So could Mylan N.V., be undervalued? Well as said before P/E is 29.96. The PEG is 2.14, P/S is 2.44 and the P/B is at 2.23. The P/cash is 19.83, with P/free cash flow at 16.34.
Mylan N.V. ability to deal with debt shows that the current ratio is 1.7, and the quick ratio is 1.1. This is with long term debt/equity at 0.62, and total debt/equity at 0.73.
In terms of margins, Mylan N.V. has a gross margin of 44.50%, an operating margin of 14.60% and a profit margin of 8.30%.Payout ratio for Mylan N.V. is 0.00%. Return on assets come to 3.60% with return on investment coming to 8.20%.
Insider ownership for Mylan N.V., is at 0.70% and institutional ownership comes to 70.90%. Outstanding shares are at 507.58. While shares float is 412.26. The float short is currently 6.55%, and short ratio is 5.42.